Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety-Reference-Cited by-同舟云学术

Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety

Published:2022-05 Issue:5 Volume:12 Page:2462-2478
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Gao Wei,Hu Hongxiang^ORCID,Dai Lipeng,He Miao,Yuan Hebao^ORCID,Zhang Huixia,Liao Jinhui,Wen Bo,Li Yan,Palmisano Maria,Traore Mohamed Dit Mady,Zhou Simon,Sun Duxin^ORCID

Funder

Celgene

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference95 articles.

1. Trends in clinical success rates and therapeutic focus;Dowden;Nat Rev Drug Discov,2019

2. The current status of drug discovery and development as originated in United States academia: the influence of industrial and academic collaboration on drug discovery and development;Takebe;Clin Transl Sci,2018

3. Phase II and Phase III failures: 2013-2015;Harrison;Nat Rev Drug Discov,2016

4. Why 90% of clinical drug development fails and how to improve it;Sun;Acta Pharm Sin B,2022

5. Activity landscape representations for structure−activity relationship analysis;Wassermann;J Med Chem,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conformation, virtual cocrystal screening, synthesis and determination of dipyridamole;Journal of Molecular Structure;2024-12

2. Characterization of active alkaloids and metabolites in rats after oral administration of Zuojin Pill using UHPLC-Q-TOF-MS combined with bioinformatics and molecular docking analyses;Journal of Pharmaceutical and Biomedical Analysis;2024-10

3. Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?;Journal of Medicinal Chemistry;2024-09-10

4. In silico off-target profiling for enhanced drug safety assessment;Acta Pharmaceutica Sinica B;2024-07

5. Progress and application of lung-on-a-chip for lung cancer;Frontiers in Bioengineering and Biotechnology;2024-05-24